Metformin versus insulin for the treatment of gestational diabetes.
Janet A Rowan, William M Hague, Wanzhen Gao, Malcolm R Battin, M Peter Moore, undefined MiG Trial Investigators
New England Journal of Medicine | Massachusetts Medical Society | Published : 2008
BACKGROUND: Metformin is a logical treatment for women with gestational diabetes mellitus, but randomized trials to assess the efficacy and safety of its use for this condition are lacking. METHODS: We randomly assigned 751 women with gestational diabetes mellitus at 20 to 33 weeks of gestation to open treatment with metformin (with supplemental insulin if required) or insulin. The primary outcome was a composite of neonatal hypoglycemia, respiratory distress, need for phototherapy, birth trauma, 5-minute Apgar score less than 7, or prematurity. The trial was designed to rule out a 33% increase (from 30% to 40%) in this composite outcome in infants of women treated with metformin as compared..View full abstract